Allergic Rhino-Conjunctivitis - Pipeline Review, Q2 2011 by GlobalMarketsDirect

VIEWS: 6 PAGES: 47

More Info
									Allergic Rhino-Conjunctivitis – Pipeline Review, Q2 2011




      Allergic Rhino-Conjunctivitis - Pipeline Review, Q2
                            2011
                                                                                          Reference Code: GMDHC575IDB

                                                                                          Publication Date: May 2011




Allergic Rhino-Conjunctivitis – Pipeline Review, Q2 2011                                                               GMDHC575IDB / Pub May 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied
                                                                                                                                          Page(1)
Allergic Rhino-Conjunctivitis – Pipeline Review, Q2 2011



Ta b le o f Co n te n ts
Table of Contents                                                                                                           2
List of Tables                                                                                                              5
List of Figures                                                                                                             6
Introduction                                                                                                                7
     Global Markets Direct Report Coverage                                                                                  7
Allergic Rhino-Conjunctivitis Overview                                                                                      8
Therapeutics Development                                                                                                    9
     An Overview of Pipeline Products for Allergic Rhino-Conjunctivitis                                                     9
Allergic Rhino-Conjunctivitis Therapeutics under Development by Companies                                                  11
Allergic Rhino-Conjunctivitis Therapeutics under Investigation by Universities/Institutes                                  12
Late Stage Products                                                                                                        13
     Comparative Analysis                                                                                                  13
Mid Clinical Stage Products                                                                                                14
     Comparative Analysis                                                                                                  14
Allergic Rhino-Conjunctivitis Therapeutics - Products under Development by Companies                                       15
Allergic Rhino-Conjunctivitis Therapeutics - Products under Investigation by Universities/Institutes                       16
Companies Involved in Allergic Rhino-Conjunctivitis Therapeutics Development                                               17
     Merck & Co., Inc.                                                                                                     17
     ALK-Abello A/S                                                                                                        17
     FAES Farma SA                                                                                                         18
     Stallergenes S.A.                                                                                                     18
     Cytos Biotechnology AG                                                                                                19
     Allergopharma Joachim Ganzer KG                                                                                       19
     Circassia Holdings Ltd.                                                                                               20
     Laboratorios LETI S.L.                                                                                                20
Allergic Rhino-Conjunctivitis - Therapeutics Assessment                                                                    21
     Assessment by Monotherapy Products                                                                                    21
     Assessment by Combination Products                                                                                    22
     Assessment by Route of Administration                                                                                 23
     Assessment by Molecule Type                                                                                           25
Drug Profiles                                                                                                              27
     CYT005-AllQbG10 - Drug Profile                                                                                        27
          Product Description                                                                                              27
          Mechanism of Action                                                                                              27
          R&D Progress                                                                                                     27
     Bilastine - Drug Profile                                                                                              28
          Product Description                                                                                              28
          Mechanism of Action                                                                                              28
          R&D Progress                                                                                                     28
     rBet v1 - Drug Profile                                                                                                29
          Product Description                                                                                              29
          Mechanism of Action                                                                                              29
          R&D Progress                                                                                                     29
     Allergen Extract - Drug Profile                                                                                       30
          Product Description                                                                                              30
          Mechanism of Action                                                                                              30
          R&D Progress                                                                                                     30


Allergic Rhino-Conjunctivitis – Pipeline Review, Q2 2011                                               GMDHC575IDB / Pub May 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied                                    Page(2)
Allergic Rhino-Conjunctivitis – Pipeline Review, Q2 2011


     Grass Pollen Allergoid - Drug Profile                                                                    31
          Product Description                                                                                 31
          Mechanism of Action                                                                                 31
          R&D Progress                                                                                        31
     SCH 697243 - Drug Profile                                                                                32
          Product Description                                                                                 32
          Mechanism of Action                                                                                 32
          R&D Progress                                                                                        32
     Olea Europaea Pollen Extract - Drug Profile                                                              33
          Product Description                                                                                 33
          Mechanism of Action                                                                                 33
          R&D Progress                                                                                        33
     Modified Allergen Extract - Drug Profile                                                                 34
          Product Description                                                                                 34
          Mechanism of Action                                                                                 34
          R&D Progress                                                                                        34
     ToleroMune Grass Allergy T-cell Vaccine - Drug Profile                                                   35
          Product Description                                                                                 35
          Mechanism of Action                                                                                 35
          R&D Progress                                                                                        35
     AL0704rP - Drug Profile                                                                                  36
          Product Description                                                                                 36
          Mechanism of Action                                                                                 36
          R&D Progress                                                                                        36
     Mutaflor - Drug Profile                                                                                  37
          Product Description                                                                                 37
          Mechanism of Action                                                                                 37
          R&D Progress                                                                                        37
     ALK Ragweed Vaccine - Drug Profile                                                                       38
          Product Description                                                                                 38
          Mechanism of Action                                                                                 38
          R&D Progress                                                                                        38
     Depigoid Birch - Drug Profile                                                                            39
          Product Description                                                                                 39
          Mechanism of Action                                                                                 39
          R&D Progress                                                                                        39
     gpASIT + TM - Drug Profile                                                                               40
          Product Description                                                                                 40
          Mechanism of Action                                                                                 40
          R&D Progress                                                                                        40
     Oralair Grasses - Drug Profile                                                                           41
          Product Description                                                                                 41
          Mechanism of Action                                                                                 41
          R&D Progress                                                                                        41
     Grass Pollen Allergenic Extract - Drug Profile                                                           42
          Product Description                                                                                 42
          Mechanism of Action                                                                                 42
          R&D Progress                                                                                        42




Allergic Rhino-Conjunctivitis – Pipeline Review, Q2 2011                                  GMDHC575IDB / Pub May 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied                       Page(3)
Allergic Rhino-Conjunctivitis – Pipeline Review, Q2 2011


     Clustoid - Drug Profile                                                                                  43
          Product Description                                                                                 43
          Mechanism of Action                                                                                 43
          R&D Progress                                                                                        43
Allergic Rhino-Conjunctivitis Therapeutics – Drug Profile Updates                                             44
     Allergic Rhino-Conjunctivitis - Featured News                                                            45
          May 24, 2011: Paladin Labs Files New Drug Submission For Oralair                                    45
Appendix                                                                                                      46
     Methodology                                                                                              46
          Coverage                                                                                            46
          Secondary Research                                                                                  46
          Primary Research                                                                                    46
          Expert Panel Validation                                                                             47
     Contact Us                                                                                               47
     Disclaimer                                                                                               47




Allergic Rhino-Conjunctivitis – Pipeline Review, Q2 2011                                  GMDHC575IDB / Pub May 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied                       Page(4)
Allergic Rhino-Conjunctivitis – Pipeline Review, Q2 2011




Lis t o f Ta b le s
Number of Products Under Development for Allergic Rhino-Conjunctivitis, Q2 2011                                     9

Products under Development for Allergic Rhino-Conjunctivitis – Comparative Analysis, Q2 2011                       10

Number of Products under Development by Companies, Q2 2011                                                         11

Number of Products under Investigation by Universities/Institutes, Q2 2011                                         12

Comparative Analysis by Late Stage Development, Q2 2011                                                            13

Comparative Analysis by Mid Clinical Stage Development, Q2 2011                                                    14

Products under Development by Companies, Q2 2011                                                                   15

Products under Investigation by Universities/Institutes, Q2 2011                                                   16

Merck & Co., Inc., 2011                                                                                            17

ALK-Abello A/S, 2011                                                                                               17

FAES Farma SA, 2011                                                                                                18

Stallergenes S.A., 2011                                                                                            18

Cytos Biotechnology AG, 2011                                                                                       19

Allergopharma Joachim Ganzer KG, 2011                                                                              19

Circassia Holdings Ltd., 2011                                                                                      20

Laboratorios LETI S.L., 2011                                                                                       20

Assessment by Monotherapy Products, Q2 2011                                                                        21

Assessment by Combination Products                                                                                 22

Assessment by Stage and Route of Administration, Q2 2011                                     
								
To top